| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |